Immunohistochemical Quantification of Heparan Sulfate Proteoglycan and Collagen IV in Skeletal Muscle Capillary Basement Membranes of Patients With Diabetic Nephropathy
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In IDDM patients, an increased permeability of the glomerular capillaries has been associated with a gen eral loss of negatively charged heparan sulfate proteo glycans (HSPGs) within basement membranes (BMs). In the present study, we used immunohistochemical stain ing to quantify heparan sulfate (HS), HSPG core pro tein, and collagen IV in capillary basement membranes of skeletal muscle biopsies taken from 9 healthy control subjects (C ) and 20 IDDM patients: 7 with normal albu min excretion rate (<30 mg/24 h) (D 0), 5 with incipient nephropathy (albumin excretion rate 30-300 mg/24 h ) (Di), and 8 with clinical nephropathy (albumin excre tion rate >300 mg/24 h) (D 2). In the capillaries, stain ing was measured by a scanning and integrating microspectrophotometer. A significant difference in the absorbance of HS was found among the four sub groups (means ± SD): 0.477 ± 0.082 (C ), 0.627 ± 0.031 (D0), 0.542 ± 0.098 (D x), and 0.371 ± 0.118 (D 2) (P = 0,006). Similarly, an overall significant difference in the absorbance of collagen IV was demonstrated (means ± SD): 0.836 ± 0.111 (C ), 0.838 ± 0.300 (D 0), 0.970 ± 0.173 (D x), and 0.512 ± 0.248 (D2) (P = 0.02). No statistical difference in the absorbance of core protein was demonstrated among the groups. W ithin the dia betic groups, IIS was inversely correlated to albumin uria (r = -0.76, P = 0.003) and albuminuria corrected for creatinine clearance (r = -0.69, P s 0.008). Because, in IDDM patients with album inuria, alterations of the content of HS and collagen IV within the capillary BM have been demonstrated immunohistochemically, not only in the glomerular filtration barrier, but also in the skeletal muscle capillary BM, we suggest that these changes reflect universal quantitative or qualitative alterations w ithin the capillary filtratio n barrier. Diabetes 46: [1875] [1876] [1877] [1878] [1879] [1880] 1997 'à ccording to the Steno hypothesis (1), in IDDM patients, album inuria reflects not only severe renal disease, but also a generalized vascular J L * J^i dysfunction, demonstrated by increased cardio vascular morbidity and mortality (2, 3) . The nature of such uni versal alterations is unknown, and might be due to both increased capillary pressure (4) and structural alterations of the macromolecular pathway between the capillary lumen and the lymphatic capillaries (i.e., the extracellular matrix [ECM]) (5) . Within the ECM, heparan sulfate proteoglycans (HSPGs) constitute a major class of proteoglycans that are found especially in basement membranes (BMs). HSPGs are formed by a central core protein to which the anionic glycosaminoglycan heparan sulfate (HS) is linked (6),
In diabetic nephropathy, renal pathobiochemical alter ations are characterized by accumulation of BM-like mate rial within the glomeruli (7) and a decreased number of anionic sites (Le., HS or HSPG) within the glomerular base ment membrane (GBM) (7) (8) (9) (10) (11) (12) . In rats, loss of GBM-HS induces albuminuria (13) , and in humans a negative corre lation between urinary albumin excretion rate (AER) and the content of HS within the GBM has been demonstrated (12) . However, patients with diabetic nephropathy suffer from not only increased macromolecular permeability w ithin the glomeruli, but also an increased extrarenal capillary per meability, as indicated by a 50% increase of the transcapil lary escape rate of album in and other plasma proteins (14,15)* Therefore we hypothesized that deficiency of HS, both in glomeruli and in the vessel walls of extrarenal tissue, is the common link between album inuria and macrovascular disease in diabetic patients with nephropathy. The aim of the present study was to evaluate possible alterations of the amount of HS in extrarenal tissue among healthy sub jects and IDDM patients with and w ithout albuminuria. We performed a quantification of HS, HSPG core protein, and collagen IV by immunohistochemistry on the BMs of skele tal muscle capillaries.
RESEARCH DESIGN AND M ETHODS
Subjects. Nine healthy control subjects (C) and twenty IDDM patients partici pated in the study. The diabetic patients were recruited from the outpatient clinic of the Steno Diabetes Center, and the control subjects were selected from the same geographic area. All IDDM patients had diabetes diagnosed before age 31 years. Diabetes duration was >10 years. All patients, except one, were on insulin treat-r i£ "x à V À . . 1. All procedures for collagen IV, IIS, and HSPG ('ore protein for all subjects were performed in one sett ing, Quantitative procedure. A minimum of 40 muscle capillaries cut in cross sec tion and located between at least three adjacent; muscle fibers (e.g., Fig. LA) were randomly selected from at least two sections on slides with the same code. If it was impossible to identify 40 capillaries for quantification, the specimen was excluded. A randomly selected area of the stained BM in each of the capillaries was scanned with a Vickers M85A scanning and integrating microspectropholomoter (Vickers, York, U.K. ) with the following machine sellings: x 100 objective (scanning area J.î.l pur), light, at the isobestic wavelength (585 run) of NBT for malins, and a scanning spot diameter of 0.2 pm. Within each area, the individual spot readings were automatically integrated by the instrument. The mean inte grated absorbance over all areas was then calculated by reference to a standard calibration graph constructed by measuring a series of neutral density Alters with known absorbance values. Because this procedure was performed on each experimental day, any day-to-day variation in the sensitivity of the mlerospeo trophotometer was eliminated. Moreover, measurements of the neutral density fillers showed that the instrument was linear within the range of absorbance val ues recorded in the capillaries. Finally, the mean fonuazau deposition measured in the absence of the primary antibody was subtracted from that measured in the presence of antibody to give a measure (± SD) of the specific antibody binding alone. Metabolic control and renal function. HbA1 (. was measured by high-perfor mance liquid chromatography (Bio Rad DIAMAT, Richmond, C'A; normal range Blood glucose was measured by means ofllypocount; B (Hypoguard LI), Wbodhridge, Suffolk, U.K.). Serum and urinary creatinine was measured by a kinetic Jaffe' s method (interassay coefficient of variation <5%). Urinary albumin concentration was determined using an enzyme-linked immunosorbent assay method (intra-and interassay coefficient of variation <0%) (17) . In «Habetic nephropathy, the glomerular nitration rat e and creat inine clearance show a strong inverst1 correlation with the percentage of occluded and globally sclerosed glomeruli (18) . We therefore corrected the albuminuria (mg/24 h) for the creati nine clearance (ml/min), yielding a ratio expresseil in pg/ml (Thble 1). This ratio of albuminuria reflects the albumin nitration in still-functioning glomeruli (12) . Statistical analyses. The slides were decoded at the end of the experiment. Data were processed using the Sl at Graphics st atistical software package (STSC, Rockville, MD) and Unislat for Windows (Unistat, London, U.K.). Results are expressed as means t SI), except, for results from AER. AEU was not normally distributed, anti the results are therefore given as median and range. Differences between groups were assessed by unpaired Kruskal-Wallis tests. Correlations were expressed by Spearman's correlation coefficients (r). P values <0.05 were accepted as significant.
RESULTS
Clinical characteristics of the study groups are given in Table  1 . The diabetic groups were comparable regarding age, diabetic duration, daily insulin dosage, and BMI, Among diabetic patients, systolic and diastolic blood pressure was signifi cantly higher in patients with albuminuria. A similar increase was observed for HbAu., although it was not significant.
Because of the exclusion criteria related to the quantitative analysis, HS, HSPG core protein, and collagen IV were quan tified in an unequal number of subjects. HS was quantified in 24 subjects. An overall significant difference was found among the four subgroups (P < 0.006) and among the diabetic groups (P = 0.01; Fig. 2A) . This was mainly due to an increase in HS absorbance within the normoalbuminuric group of Fig. 3 ) was observed.
Collagen IV was quantified in 28 subjects. An overall sig nificant difference in absorbance was found among the four subgroups (P = s 0.02) and among the three diabetic groups (P = 0.03; Fig. 2B ), This was mainly due to a decrease of colla gen IV within the group of patients having clinical nephropa thy: 0.836 ± 0.111 (C), 0.838 ± 0.300 (D0), 0.970 ± 0.173 (D,), and 0.512 ± 0.248 (D2). Within the diabetic group, collagen IV absorbance revealed a significant inverse correlation with albuminuria corrected for creatinine clearance (r --0.57, P = 0.02). The coefficient of variation was 3.5, 2.2, and 2,8%, respectively, when three sections stained for collagen IV were measured on each of 10 days.
HSPG core protein was quantified in 28 subjects. Among the groups no significant difference in absorbance was revealed: 0.985 ± 0.150 (C), 0.868 ± 0.146 (D0), 1.126 ± 0.24 (Dj), and 0.894 ± 0.097 (D2) (P = 0.12; Fig. 2Ç) .
No correlation between HS absorbance and HbAlc, post prandial blood glucose, or diabetes duration was demon strated in the entire population or within the diabetic groups. Also, the absorbance of collagen IV and HSPG core protein was unrelated to HbAlc. Furthermore, if the diabetic sub jects enrolled for the measurements of HS, collagen IV, or HSPG core protein absorbance were stratified into two groups defined by a HbAlc level above or below the median value, no significant difference in absorbance was demon strated between groups.
D IS C U S S IO N
Previously, a comparable decrease of GBM-HS or HSPG core protein has been demonstrated in diabetic kidney dis ease, although the results have been restricted by the use of semiquantitative analysis (7, 9, 10, 12) , In the present study, a reproducible quantitative immunohistochemical analysis was used to estimate the concentration of HS, HSPG core protein, and collagen IV within capillary BMs of skeletal muscle biopsies. The present data document for the first time an extrarenal reduction of capillary BM-HS in patients with diabetic nephropathy.
Such an alteration of BM-HS absorbance in IDDM patients may be explained by altered antibody-epitope interaction. Recently, we showed that the JM403 binding to HS is depen dent on the presence of an N-unsubstituted glucosamine unit in HS, and that the JM403 epitope expression in HS prepara tions from various sources is inversely correlated with HS sul fation (19). The HS chains are modified posttranscriptionally by N-substitution of the glucosamine units, facilitated by the key enzyme glucosaminyl N-deacetylase/N-sulphotransferase. This enzyme has been found to be decreased in both diabetic animals (20, 21) and diabetic patients (22) . Thus, in the pre sent study, the increase of HS absorbance in the D0 group might be related to an undersulfation of HS. Consequently, our finding of decreased HS absorbance in patients with albu minuria might be explained by oversulfation of HS; that is, a decrease in the number of N-unsubstituted glucosamine units of HS or a decreased content of HS in the BM of muscle cap illaries. Along the same line, our observation of decreased absorbance of HS in the D2 group might be due to an absolute decrease of HS within muscle capillary BM, as was previously demonstrated in the GBM of diabetic patients with albumin uria (11) . We therefore suggest that the first change in HSPG in diabetes is probably an undersulfation of HS (the D0 group), followed by an absolute decrease of HS (the Dx and D2 groups), as has been discussed previously (23) . An absolute reduction of BM-HS could be genetically deter mined. Thus an altered gene transcription or posttranscriptional modification of the first domain within the HSPG2-gene coding for the amino acid sequence at the protein HSattachment sites (24) could be responsible for the observed "loss" of HS. Such a qualitative alteration within the HSPG core protein might not have been detected in the present quantification.
Theoretically, the reduced quantity of HS could be due to masking of epitopes, either by nonenzymatic glycation of the 1878 DIABETES, VOL, 46, NOVEMBER 1997 primary amino group on IIS recognized by JM403, or by increasing amounts of other BM proteins, such as collageus, laminin, or fibronectin (7,9), perhaps induced by transforming Growth faetor-ß overexpression (25) . Thus it has been inter preted that structural changes in the GBM prevent the normal organization of HSPG, making it inaccessible to specific anti bodies (2(5) , and thereby blurring the use' of imnumohistochemistry to draw conclusions about quantitative changes in macromolecular compositions. In the present study, the influ ence of nonenzymatie glycation seems to be negligible, since IIS absorbance did not correlate with metabolic regulation. Also, a relationship bet ween collagen IV and a reduction of I IS seems unlikely, given that a concomitant decrease of both molecules was found in diabetic patients with nephropathy. This is in agreement, with the findings of Tamsma et a l (12) , who studied the GI1M of IDDM patients with advanced nephropathy, but., disagrees with findings from other studies in which increasing amounts of GBM-collagen IV in diabetic patients with albuminuria were reported (7, 9, 27) . Conflicting results might be due to the inclusion of patients with different degrees of albuminuria, since it, has been demonstrated that; collagen IV expression is increased in the early stage of dia betic nephropathy and decreased in more advanced stages (28, 29) . Further, different results might be obtained due to the use of anti-collagen IV antibodies with different specificities (directed against either w ,/u.» or a/u,,). We used a commercial monoclonal anti-collagen IV antibody in which the specific binding sites have' not been identified.
In accordance with two former studies, we demonstrated that the content of BM-HS in muscle capillaries is inversely correlated to the degree of albuminuria (9,12), Because an increased glomerular leakiness of albumin in diabetic patients has been related to an increased systemic transcap illary albumin escape rate (14) , we interpret our data as sup porting the hypothesis of a funct ional relationship bet ween a decreased content of BM-IIS and a general increased trans» capillary escape rat e' of albumin ( 1 ), although in the present study the latter could not be measured. In addition, our data demonstrated an inverse correlation between collagen IV absorbance and albuminuria corrected for creatinine clear ance, thereby indicating that , besides HS, changes in collagen IV might also contribute to an enhanced diabetes-related ECM permeability. patients with nephropathy. Accordingly, we suggest that albuminuria in insulin-dependent diabetic* patients reflects uni versal quantitative or qualitative alterations of the capillary fil tration barrier.
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